Bryan Kobel
Chief Executive Officer at TC BIOPHARM (HOLDINGS) PLC
Net worth: 773 $ as of 2023-11-29
Profile
Bryan Kobel is currently the Chief Executive Officer & Director at TC Biopharm (Holdings) Plc, as well as the CEO-Biopharm North America and Chief Executive Officer at TC BioPharm (North America), Inc. He previously worked as the Managing Director at Laidlaw & Co. (UK) Ltd.
from 2012 to 2017, Managing Director at The Alberleen Group LLC from 2018 to 2020, and Head-Capital Markets at R.F.
Lafferty & Co., Inc. from 2017 to 2018.
He also served as the Head-Healthcare Investment Banking at HUTN, Inc. Mr. Kobel received his undergraduate degree from Franklin & Marshall College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-05 | 2,101 ( 0.22% ) | 773 $ | 2023-11-29 |
Bryan Kobel active positions
Companies | Position | Start |
---|---|---|
TC BIOPHARM (HOLDINGS) PLC | Chief Executive Officer | 2021-05-31 |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - |
TC BioPharm (North America), Inc. | Chief Executive Officer | 2021-05-31 |
Former positions of Bryan Kobel
Companies | Position | End |
---|---|---|
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Corporate Officer/Principal | 2020-09-30 |
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Corporate Officer/Principal | 2018-05-31 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Corporate Officer/Principal | 2017-03-31 |
HUTN, INC. | Corporate Officer/Principal | - |
Training of Bryan Kobel
Franklin & Marshall College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
HUTN, INC. | Finance |
TC BIOPHARM (HOLDINGS) PLC | Health Technology |
Private companies | 5 |
---|---|
R.F. Lafferty & Co., Inc.
R.F. Lafferty & Co., Inc. Investment Banks/BrokersFinance Founded in 1946, R.F. Lafferty & Co., Inc. is a brokerage firm and registered investment advisor located in New York City. The firm's research focuses on small- and mid-cap companies. | Finance |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010. | Finance |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY. | Finance |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
TC BioPharm (North America), Inc. |
- Stock Market
- Insiders
- Bryan Kobel